Latest Market News

Simonds Group reported a stable $665.6 million revenue for FY25, with normalised net profit after tax surging 90% to $5.7 million, driven by the acquisition of Dennis Family Homes and improved margins.

Simonds Group Limited reported steady revenue of $665.6 million for FY2025, alongside a modest net profit of $1.015 million, as it completed the strategic acquisition of Dennis Family Homes. The company is focused on integrating the acquisition and driving growth amid a recovering housing market.

360 Capital REIT (ASX, TOT) reported a modest statutory net profit for FY25 and projects a fully tax-deferred distribution yield of 7.6% for FY26, underpinned by a modern, well-leased portfolio and strategic growth initiatives.

Bass Oil reported steady oil production in July alongside progress in acquiring the Vanessa gas field and advancing deep coal commercialisation efforts.

Regal Asian Investments Limited posted a sharp 92% decline in net profit for FY25 amid volatile Asian markets but maintained a fully franked 6 cent dividend and continued its on-market share buy-back program.

Kogan.com has recorded a significant non-cash goodwill impairment related to its Mighty Ape acquisition, reflecting ongoing challenges in New Zealand’s retail market and delayed technology recovery.

Pacgold Limited advances its Northern Queensland footprint with a maiden 900,000-ounce gold resource at Alice River and a new high-grade antimony acquisition at St George, positioning itself amid critical mineral supply challenges.

Pacgold Limited has entered a farm-in agreement to acquire up to 100% of the St George Gold-Antimony Project in North Queensland, unlocking exposure to a critical mineral with soaring prices and strong geopolitical demand.

Universal Biosensors has extended the due diligence period with major investor Viburnum Funds as it continues to negotiate a secured loan facility, with no binding commitment yet reached.

360 Capital REIT (ASX – TOT) has reported a return to profitability in FY25, extending its debt facility and completing key leasing deals, while preparing for leasing challenges in FY26.

Highfield Resources faces a setback as China Minmetals and its subsidiary withdraw from a key strategic investment, triggering the maturity of convertible notes and raising questions about the future financing of the Muga potash project.

ReNerve Limited has achieved a key milestone with its first sale and clinical use of a deep dermal tissue product in the US, broadening its surgical applications beyond nerve repair. This move complements its existing nerve repair portfolio and sets the stage for further product launches later this year.